D-0285-2022 Class III Terminated
FDA drug recall D-0285-2022 was initiated by Torrent Pharma Inc. on December 1, 2021 and is designated Class III. Reason for recall: Superpotent; Hydrochlorothiazide The recall status is terminated (terminated May 12, 2024). Affected quantity: 27,312 Bottles.
Recall Details
- Product Type
- Drugs
- Report Date
- December 22, 2021
- Initiation Date
- December 1, 2021
- Termination Date
- May 12, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 27,312 Bottles
Product Description
Telmisartan and Hydrochlorothiazide Tablets, USP, 40 mg/12.5 mg, 30 count bottles, Rx only, Manufactured by: Torrent Pharmaceuticals LTD., Indrad-382 721, India. Manufactured for: Torrent Pharma Inc., Basking Ridge, NJ 07920. NDC: 13668-159-30
Reason for Recall
Superpotent; Hydrochlorothiazide
Distribution Pattern
Nationwide USA
Code Information
Batch: BZ74G001 Exp. 12/2021.